<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Techniques Used | Cancer Biotechnology</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">

  <style>
    body {
      font-family: Arial, Helvetica, sans-serif;
      margin: 0;
      padding: 0;
      background-color: #f4f7fb;
      color: #333;
	  margin-top: 160px;
    }
    header {
  position: fixed;
  top: 0;
  left: 0;
  width: 100%;
  background: linear-gradient(90deg, #7b2cbf, #5a189a);
  color: white;
  padding: 20px;
  text-align: center;
  z-index: 1000;
  padding-top: 54px;
}

    nav {
  position: fixed;
  top: 153px; /* height of header */
  left: 0;
  width: 100%;
  background-color: #240046;
  padding: 10px;
  text-align: center;
  z-index: 999;
}

    nav a {
      color: white;
      margin: 0 15px;
      text-decoration: none;
      font-weight: bold;
    }

    nav a:hover {
      text-decoration: underline;
    }

    section {
      background: white;
      margin: 30px auto;
      padding: 30px;
      max-width: 1100px;
      border-radius: 8px;
      box-shadow: 0 0 12px rgba(0,0,0,0.1);
    }

    h2 {
      color: #5a189a;
      margin-bottom: 15px;
    }

    h3 {
      color: #7b2cbf;
    }

    .content-block {
      display: flex;
      gap: 40px;
      align-items: center;
      margin-bottom: 40px;
    }


    ul {
      line-height: 1.8;
    }

    footer {
      background-color: #240046;
      color: white;
      text-align: center;
      padding: 15px;
      margin-top: 40px;
    }
	
		html {
  scroll-behavior: smooth;
} 
section {
  scroll-margin-top: 170px;
}

    @media (max-width: 768px) {
      .content-block {
        flex-direction: column;
      }
    }
	
	.accordion {
  max-width: 1000px;
  margin: auto;
}

.accordion-item {
  margin-bottom: 15px;
  border-radius: 6px;
  overflow: hidden;
  box-shadow: 0 0 8px rgba(0,0,0,0.1);
}

.accordion-header {
  width: 100%;
  background-color: #5a189a;
  color: white;
  padding: 15px 20px;
  text-align: left;
  font-size: 16px;
  font-weight: bold;
  border: none;
  cursor: pointer;
  transition: background 0.3s;
}

.accordion-header:hover {
  background-color: #7b2cbf;
}

.accordion-content {
  display: none;
  background-color: #fff;
  padding: 20px;
  line-height: 1.8;
}

.accordion-content ul {
  margin-left: 20px;
}
.accordion-header {
  position: relative;
  padding-right: 45px; /* space for icon */
}

/* Plus icon by default */
.accordion-header::after {
  content: "+";
  position: absolute;
  right: 20px;
  font-size: 22px;
  font-weight: bold;
  transition: transform 0.3s ease;
}

/* Minus icon when active */
.accordion-header.active::after {
  content: "‚àí";
}
@media (max-width: 768px) {
  .accordion-content img {
    float: none;
    display: block;
    margin: 0 auto 15px auto;
  }
}


  </style>
</head>

<body>

<header>
  <h1>Cancer Biotechnology</h1>
</header>
 
<nav>
  <a href="cancer biotech.html">Home</a>
  <a href="types.html">Types of Cancer</a>
  <a href="cellculture.html">Cell Culture</a>
  <a href="techniques.html">Techniques</a>
  <a href="therapy.html">Therapy</a>
  <a href="future.html">Future Scope</a>
</nav>

<section>
<br/>
  <h2>‚öôÔ∏è Biotechnological Techniques Used</h2>
<hr>
<br/>
  <div class="accordion">

    <!-- Recombinant DNA -->
    <!-- Recombinant DNA Technology -->
<div class="accordion-item">
  <button class="accordion-header">
    Recombinant DNA (rDNA) Technology
  </button>
  <div class="accordion-content">
    <p>
      <img src="D:/Office Files/recombinant dna technology.webp" alt="Recombinant DNA Technology"
           style="float:right; width:40%; max-width:370px; margin-left:20px; margin-bottom:15px; border-radius:8px; box-shadow:0 0 8px rgba(0,0,0,0.1);">
      Recombinant DNA (rDNA) technology is a powerful biotechnological technique
      used to produce therapeutic proteins by combining DNA from different biological sources.
      In cancer biotechnology, it enables large-scale production of human proteins
      for diagnosis, treatment, and immune modulation.
    </p> 

    <p>
      Using rDNA technology, the gene encoding a desired therapeutic protein is
      isolated and inserted into a suitable host organism such as bacteria, yeast,
      or mammalian cells. These host cells act as biological factories, producing
      large quantities of the required protein with high purity and consistency.
    </p>

    <h4>‚öôÔ∏è Steps Involved in Production of Therapeutic Proteins</h4>
    <ul>
      <li><b>Isolation of the Gene:</b> Identify and isolate the gene coding for the therapeutic protein (e.g., insulin, interferon) from human DNA.</li>
      <li><b>Insertion into Vector:</b> Insert the isolated gene into a vector (usually a plasmid) using restriction enzymes and DNA ligase.</li>
      <li><b>Transformation into Host Cell:</b> Introduce the recombinant plasmid into a host cell such as E. coli, yeast, or CHO cells.</li>
      <li><b>Expression of Protein:</b> The host cell expresses the inserted gene and produces the therapeutic protein.</li>
      <li><b>Purification:</b> Extract and purify the protein to remove impurities and ensure safety for medical use.</li>
    </ul>

    <h4>üß¨ Role in Cancer Biotechnology</h4>
    <ul>
      <li>Interferons ‚Äì Enhance immune response against cancer cells</li>
      <li>Interleukins ‚Äì Stimulate immune cell growth and activity</li>
      <li>Tumor Necrosis Factor (TNF) ‚Äì Induces cancer cell death</li>
      <li>Growth factors ‚Äì Used in tissue repair after cancer therapy</li>
      <li>Recombinant antibodies ‚Äì Used in targeted cancer therapy</li>
    </ul>

    <h4>‚úÖ Advantages of Recombinant Therapeutic Proteins</h4>
    <ul>
      <li>High purity and safety</li>
      <li>Reduced risk of allergic reactions</li>
      <li>Large-scale and cost-effective production</li>
      <li>Proteins identical or similar to human proteins</li>
    </ul>
  </div>
</div>



    <!-- Monoclonal Antibodies -->
<!-- Monoclonal Antibody Technology -->
<div class="accordion-item">
  <button class="accordion-header">
    Monoclonal Antibody (mAb) Technology
  </button>
  <div class="accordion-content">
    <p>
	<img src="D:/Office Files/monoclonal antibodies.png" alt="Monoclonal Antibody Technology"
           style="float:right; width:45%; max-width:430px; margin-left:20px; margin-bottom:15px; border-radius:8px; box-shadow:0 0 8px rgba(0,0,0,0.1);">
      Monoclonal antibody (mAb) technology is a highly specific biotechnological approach
      used in targeted cancer therapy. Monoclonal antibodies are identical antibodies
      produced from a single clone of immune cells and are designed to recognize
      specific antigens present on cancer cells.
    </p>

    <p>
      Unlike conventional chemotherapy, which affects both normal and cancerous cells,
      monoclonal antibodies selectively bind to tumor-specific or tumor-associated antigens,
      minimizing damage to healthy tissues and reducing side effects.
    </p>

    <h4>‚öôÔ∏è Production of Monoclonal Antibodies (Hybridoma Technology)</h4>
    <ul>
      <li><b>Immunization:</b> A mouse is immunized with a specific cancer antigen.</li>
      <li><b>Isolation of B-Lymphocytes:</b> Antibody-producing B-cells are isolated from the spleen.</li>
      <li><b>Fusion with Myeloma Cells:</b> B-cells are fused with immortal myeloma cells to form hybridoma cells.</li>
      <li><b>Selection and Screening:</b> Hybridomas producing the desired antibody are selected.</li>
      <li><b>Large-scale Production:</b> Selected hybridomas are cultured to produce monoclonal antibodies in bulk.</li>
    </ul>
    <p>Modern approaches also include <b>humanized and fully human monoclonal antibodies</b> to reduce immune reactions.</p>

    <h4>üß¨ Mechanism of Action in Cancer Therapy</h4>
    <ul>
      <li>Blocking growth factor receptors on cancer cells</li>
      <li>Inducing immune-mediated cell destruction (ADCC, CDC)</li>
      <li>Delivering toxic agents or radioactive substances directly to tumor cells</li>
      <li>Inhibiting angiogenesis, preventing tumor blood supply</li>
      <li>Checkpoint inhibition to activate immune response</li>
    </ul>

    <h4>üéØ Examples of Monoclonal Antibodies Used in Cancer</h4>
    <table border="1" cellpadding="8" cellspacing="0" style="border-collapse: collapse; width: 100%; margin-bottom: 20px;">
      <thead>
        <tr style="background-color: #7b2cbf; color: white;">
          <th>Monoclonal Antibody</th>
          <th>Target</th>
          <th>Cancer Type</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td>Trastuzumab</td>
          <td>HER2 receptor</td>
          <td>Breast cancer</td>
        </tr>
        <tr>
          <td>Rituximab</td>
          <td>CD20 antigen</td>
          <td>Lymphoma</td>
        </tr>
        <tr>
          <td>Bevacizumab</td>
          <td>VEGF</td>
          <td>Colorectal cancer</td>
        </tr>
        <tr>
          <td>Cetuximab</td>
          <td>EGFR</td>
          <td>Head & neck cancer</td>
        </tr>
        <tr>
          <td>Nivolumab</td>
          <td>PD-1</td>
          <td>Lung cancer</td>
        </tr>
      </tbody>
    </table>

    <h4>‚úÖ Advantages of Monoclonal Antibody Therapy</h4>
    <ul>
      <li>High specificity for cancer cells</li>
      <li>Reduced damage to normal cells</li>
      <li>Improved treatment outcomes</li>
      <li>Can be combined with chemotherapy or radiotherapy</li>
      <li>Suitable for personalized medicine</li>
    </ul>
  </div>
</div>


    <!-- CRISPR -->
<!-- CRISPR-Cas9 -->
<div class="accordion-item">
  <button class="accordion-header">
    CRISPR-Cas9
  </button>
  <div class="accordion-content">
    <p>
	<img src="D:/Office Files/CRISPR.png" alt="CRISPR" style="float:right; width:40%; max-width:370px; margin-left:20px; margin-bottom:15px; border-radius:8px; box-shadow:0 0 8px rgba(0,0,0,0.1);">
      CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats‚ÄìCas9)
      is a revolutionary gene-editing technology that allows precise modification of DNA.
      In cancer research, CRISPR-Cas9 is widely used to identify cancer-causing genes,
      study mutations, and develop targeted therapies.
    </p>

    <p>
      This technology is faster, cheaper, and more accurate compared to older gene-editing
      methods such as ZFNs and TALENs.
    </p>

    <h4>‚öôÔ∏è Components of CRISPR-Cas9 System</h4>
    <ul>
      <li><b>Cas9 enzyme:</b> Acts as molecular scissors to cut DNA</li>
      <li><b>Guide RNA (gRNA):</b> Directs Cas9 to the specific DNA sequence</li>
      <li><b>Target DNA:</b> Gene to be edited</li>
    </ul>

    <h4>üß™ Mechanism of Action</h4>
    <ol>
      <li>Guide RNA binds to the target DNA sequence.</li>
      <li>Cas9 enzyme creates a double-strand break in DNA.</li>
      <li>Cell repairs the break using:
        <ul>
          <li>Non-homologous end joining (NHEJ) ‚Üí gene knockout</li>
          <li>Homology-directed repair (HDR) ‚Üí precise gene correction</li>
        </ul>
      </li>
    </ol>
    <p>This allows addition, deletion, or modification of genes.</p>

    <h4>üî¨ Applications of CRISPR-Cas9 in Cancer Research</h4>
    <ul>
      <li><b>Identification of Cancer Genes:</b> Helps identify oncogenes and tumor suppressor genes; studies mutations responsible for cancer initiation</li>
      <li><b>Studying Cancer Progression:</b> Analyzes role of specific genes in cell proliferation, metastasis, angiogenesis, and drug resistance</li>
      <li><b>Drug Target Validation:</b> Confirms whether a gene is a valid drug target; improves anticancer drug development accuracy</li>
      <li><b>Development of Personalized Cancer Therapy:</b> Enables patient-specific gene correction; used to modify immune cells (e.g., CAR-T cell therapy)</li>
      <li><b>Cancer Model Development:</b> Creates genetically modified cancer cell lines and animal models; helps study tumor behavior under controlled conditions</li>
    </ul>

    <h4>‚úÖ Advantages of CRISPR-Cas9 in Cancer Research</h4>
    <ul>
      <li>High precision and efficiency</li>
      <li>Cost-effective and time-saving</li>
      <li>Can target multiple genes simultaneously</li>
      <li>Powerful tool for functional genomics</li>
      <li>Accelerates cancer drug discovery</li>
    </ul>
	
	<h4>‚ö†Ô∏è Limitations</h4>
    <ul>
      <li>Off-target gene edits</li>
      <li>Ethical concerns in human genome editing</li>
      <li>Delivery challenges in clinical applications</li>
    </ul>
  </div>
</div>
 

    <!-- Bioinformatics -->
<!-- Bioinformatics -->
<div class="accordion-item">
  <button class="accordion-header">
    Bioinformatics
  </button>
  <div class="accordion-content">
    <p>
	<img src="D:/Office Files/bioinfomatics.png" alt="Bioinformatics" style="float:right; width:40%; max-width:370px; margin-left:20px; margin-bottom:15px; border-radius:8px; box-shadow:0 0 8px rgba(0,0,0,0.1);">
      Bioinformatics is an interdisciplinary field that combines biology, computer science,
      and statistics to analyze biological data. In cancer research, bioinformatics
      plays a crucial role in analyzing cancer genomes, helping scientists understand
      genetic mutations, tumor heterogeneity, and disease progression.
    </p>

    <p>
      With the advancement of next-generation sequencing (NGS), massive amounts of genomic
      data are generated, which require bioinformatics tools for interpretation.
    </p>

    <h4>üß™ Cancer Genome Analysis</h4>
    <p>
      Cancer genome analysis involves studying DNA, RNA, and epigenetic changes in cancer
      cells compared to normal cells. These analyses help identify:
    </p>
    <ul>
      <li>Genetic mutations</li>
      <li>Copy number variations</li>
      <li>Chromosomal rearrangements</li>
      <li>Gene expression changes</li>
    </ul>

    <h4>üî¨ Applications of Bioinformatics in Cancer Genome Analysis</h4>
    <ul>
      <li><b>Identification of Cancer-Causing Mutations:</b>
        <ul>
          <li>Detects mutations in oncogenes and tumor suppressor genes</li>
          <li>Identifies driver mutations responsible for cancer development</li>
        </ul>
      </li>
      <li><b>Comparative Genomic Analysis:</b>
        <ul>
          <li>Compares normal and cancer genomes</li>
          <li>Helps understand tumor initiation and progression</li>
        </ul>
      </li>
      <li><b>Gene Expression Profiling:</b>
        <ul>
          <li>Uses RNA-seq and microarray data</li>
          <li>Identifies genes that are over-expressed or under-expressed in cancer</li>
          <li>Helps classify cancer subtypes</li>
        </ul>
      </li>
      <li><b>Personalized Cancer Medicine:</b>
        <ul>
          <li>Analyzes patient-specific genomic data</li>
          <li>Helps select the most effective targeted therapy</li>
          <li>Reduces adverse drug reactions</li>
        </ul>
      </li>
      <li><b>Drug Target Identification:</b>
        <ul>
          <li>Identifies potential molecular targets for anticancer drugs</li>
          <li>Predicts drug resistance mechanisms</li>
        </ul>
      </li>
      <li><b>Cancer Biomarker Discovery:</b>
        <ul>
          <li>Identifies diagnostic, prognostic, and predictive biomarkers</li>
          <li>Helps in early cancer detection and prognosis</li>
        </ul>
      </li>
    </ul>

    <h4>üõ†Ô∏è Bioinformatics Tools Used in Cancer Research</h4>
    <ul>
      <li>NCBI, Ensembl ‚Äì genome databases</li>
      <li>BLAST ‚Äì sequence alignment</li>
      <li>TCGA (The Cancer Genome Atlas) ‚Äì cancer genomic datasets</li>
      <li>GEO ‚Äì gene expression data</li>
      <li>Galaxy, R, Python ‚Äì data analysis platforms</li>
    </ul>

    <h4>‚úÖ Advantages of Bioinformatics in Cancer Research</h4>
    <ul>
      <li>Handles large-scale genomic data efficiently</li>
      <li>Improves accuracy of cancer diagnosis</li>
      <li>Supports personalized and precision medicine</li>
      <li>Reduces experimental cost and time</li>
      <li>Enhances understanding of cancer biology</li>
    </ul>
	
	<h4>‚ö†Ô∏è Limitations</h4>
    <ul>
      <li>Requires high computational expertise</li>
      <li>Data interpretation can be complex</li>
      <li>Dependent on quality of sequencing data</li>
    </ul>
  </div>
</div>


    <!-- Flow Cytometry -->
    <!-- Flow Cytometry -->
<div class="accordion-item">
  <button class="accordion-header">
    Flow Cytometry
  </button>
  <div class="accordion-content">
    <p>
	<img src="D:/Office Files/flow-cytometry.webp" alt="Flow Cytometry" style="float:right; width:40%; max-width:370px; margin-left:20px; margin-bottom:15px; border-radius:8px; box-shadow:0 0 8px rgba(0,0,0,0.1);">
      Flow cytometry is a powerful analytical technique used to measure the physical
      and chemical characteristics of individual cells as they flow in a fluid stream
      through a laser beam. In cancer research, it allows rapid and accurate examination
      of thousands of cells per second.
    </p>

    <h4>‚öôÔ∏è Principle of Flow Cytometry</h4>
    <ul>
      <li>Cells are labeled with fluorescent antibodies</li>
      <li>Cells pass one by one through a laser beam</li>
      <li>Light signals (scatter and fluorescence) are detected</li>
      <li>Data is analyzed using computer software</li>
    </ul>
    <p>This technique provides quantitative and multiparametric data about cells.</p>

    <h4>üß™ Applications in Cancer Cell Population Analysis</h4>
    <ul>
      <li><b>Identification of Cancer Cell Types:</b>
        <ul>
          <li>Differentiates cancer cells based on surface and intracellular markers</li>
          <li>Helps classify leukemia and lymphoma types</li>
        </ul>
      </li>
      <li><b>Cell Cycle Analysis:</b>
        <ul>
          <li>Measures DNA content to determine cell cycle phases</li>
          <li>Identifies rapidly dividing cancer cells</li>
        </ul>
      </li>
      <li><b>Apoptosis Detection:</b>
        <ul>
          <li>Detects programmed cell death using annexin V and PI staining</li>
          <li>Evaluates effectiveness of anticancer treatments</li>
        </ul>
      </li>
      <li><b>Detection of Cancer Stem Cells:</b>
        <ul>
          <li>Identifies rare subpopulations responsible for tumor recurrence</li>
          <li>Uses specific stem cell markers</li>
        </ul>
      </li>
      <li><b>Minimal Residual Disease (MRD) Detection:</b>
        <ul>
          <li>Detects very small numbers of remaining cancer cells after therapy</li>
          <li>Important for monitoring treatment success</li>
        </ul>
      </li>
    </ul>

    <h4>üß¨ Role in Hematological Cancers</h4>
    <p>
      Flow cytometry is especially important in leukemia, lymphoma, and multiple myeloma.
      It helps in diagnosis, classification, prognosis, and therapy monitoring.
    </p>

    <h4>‚úÖ Advantages of Flow Cytometry</h4>
    <ul>
      <li>Rapid analysis of thousands of cells</li>
      <li>High sensitivity and specificity</li>
      <li>Multiparameter analysis</li>
      <li>Requires small sample volume</li>
      <li>Quantitative and reproducible results</li>
    </ul>
	
	<h4>‚ö†Ô∏è Limitations</h4>
    <ul>
      <li>Expensive instrumentation</li>
      <li>Requires technical expertise</li>
      <li>Fluorescent overlap may affect results</li>
    </ul>
  </div>
</div>


  </div>
</section>



<footer>
  <p>Prepared by: Biotechnology Student</p>
  <p>Subject: Cancer Biotechnology</p>
</footer>
<script>
  const headers = document.querySelectorAll(".accordion-header");

  headers.forEach(header => {
    header.addEventListener("click", () => {
      const content = header.nextElementSibling;
      const isOpen = header.classList.contains("active");

      // Close all accordions
      document.querySelectorAll(".accordion-content").forEach(c => {
        c.style.display = "none";
      });
      document.querySelectorAll(".accordion-header").forEach(h => {
        h.classList.remove("active");
      });

      // Toggle current accordion
      if (!isOpen) {
        content.style.display = "block";
        header.classList.add("active");
      }
    });
  });
</script>



</body>
</html>
